These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7369864)

  • 41. Alterations of maternal estrogen levels during gestation affect the skeleton of female offspring.
    Migliaccio S; Newbold RR; Bullock BC; Jefferson WJ; Sutton FG; McLachlan JA; Korach KS
    Endocrinology; 1996 May; 137(5):2118-25. PubMed ID: 8612556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histological observations on the failure of rachitic rat bones to respond to 1,25/OH)2D3.
    Gallagher JA; Lawson DE
    Calcif Tissue Int; 1980; 31(3):215-23. PubMed ID: 6258762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 1,25 dihydroxycholecalciferol treatment of uraemic rats after high magnesium feeding.
    Binswanger U; Schiffl H; Huggler M; Becker C
    Proc Eur Dial Transplant Assoc; 1980; 17():563-8. PubMed ID: 6894642
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the effects of vitamin D metabolites on collagen synthesis and resportion of fetal rat bone in organ culture.
    Raisz LG; Kream BE; Smith MD; Simmons HA
    Calcif Tissue Int; 1980; 32(2):135-8. PubMed ID: 6773630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of dietary protein on the biological activity of cholecalciferol and its metabolites in the rachitic rat.
    Raghuramulu N; DeLuca HF
    J Nutr; 1980 Jan; 110(1):28-34. PubMed ID: 6243702
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relative effectiveness of vitamin D metabolites in increasing bone mineral solubility.
    Somerman MJ; Neuman WF
    Calcif Tissue Int; 1981; 33(2):159-65. PubMed ID: 6783272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparative study of the calcification-promoting action of 1,25 (OH)2D3 and calcitonin on the growth cartilage of rats with 1-hydroxyethylidene-1, 1-biphosphonic acid (HEBP)-induced rickets.
    Eguchi M; Shibata K; Wada F; Kawamura H; Shimauchi T; Shiota E; Sugioka Y
    Int Orthop; 1987; 11(1):77-82. PubMed ID: 3104219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different responses of trabecular and cortical bone to 1,25(OH)2D3 infusion.
    Bikle DD; Halloran BP; McGalliard-Cone C; Morey-Holton E
    Am J Physiol; 1990 Nov; 259(5 Pt 1):E715-22. PubMed ID: 2240210
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis.
    Berl T; Berns AS; Huffer WE; Alfrey AC; Arnaud CD; Schrier RR
    Contrib Nephrol; 1980; 18():72-81. PubMed ID: 6243528
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
    Berl T; Berns AS; Hufer WE; Hammill K; Alfrey AC; Arnaud CD; Schrier RW
    Ann Intern Med; 1978 Jun; 88(6):774-80. PubMed ID: 208439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats.
    Gunness-Hey M; Gera I; Fonseca J; Raisz LG; Hock JM
    Calcif Tissue Int; 1988 Nov; 43(5):284-8. PubMed ID: 3145794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of thyroparathyroidectomy of calcium metabolism in rats: role of 1,25-dihydroxyvitamin D3.
    Rizzoli R; Fleisch H; Bonjour JP
    Am J Physiol; 1977 Sep; 233(3):E160-4. PubMed ID: 910902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.
    Gunness-Hey M; Hock JM; Gera I; Fonseca J; Poser J; Bevan J; Raisz LG
    Calcif Tissue Int; 1986 Apr; 38(4):234-8. PubMed ID: 3085902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of 1,25(OH)2D3 and 24,25(OH)2D3 on experimental rickets.
    Kraft D; Offermann G; Steldinger R; Gawlik D
    Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):571-80. PubMed ID: 523788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased 1,25-dihydroxycholecalciferol and increased 25-hydroxy- and 24,25-dihydroxycholecalciferol in tissues of rats treated with thyroxine.
    Weisman Y; Eisenberg Z; Lubelski R; Spirer Z; Edelstein S; Harell A
    Calcif Tissue Int; 1981; 33(4):445-7. PubMed ID: 6271357
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early effect of 25-hydroxycholecalciferol (25-OH-D3) and 1,25-dihydroxycholecalciferol (1,25-(OH)2-D3) on the ability of parathyroid hormone (PTH) to elevate cyclic AMP of intact bone cells.
    Mahgoub A; Sheppard H
    Biochem Biophys Res Commun; 1975 Feb; 62(4):901-7. PubMed ID: 164197
    [No Abstract]   [Full Text] [Related]  

  • 57. Synthesis of 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by calvarial cells. Characterization of the enzyme systems.
    Puzas JE; Turner RT; Howard GA; Brand JS; Baylink DJ
    Biochem J; 1987 Jul; 245(2):333-8. PubMed ID: 3499143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats.
    Goodman WG; Baylink DJ; Sherrard DJ
    Calcif Tissue Int; 1984 Mar; 36(2):206-13. PubMed ID: 6430503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The influence of 1 alpha,25- and 24(R),25-dihydroxyvitamin D3 on bone constituents during early mineralization in the rat.
    Vukicević S; Bagi C; Vujicić G; Krempien B; Stavljenić A; Herak M
    Bone Miner; 1986 Oct; 1(5):383-96. PubMed ID: 3509782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of effect of hypomagnesemia on elevated plasma 1,25-dihydroxycholecalciferol in acutely phosphate-deprived rats.
    Kurokawa K; Haussler MR
    Endocrinology; 1978 Jun; 102(6):1864-6. PubMed ID: 744053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.